Skip to main content

Table 1 Inclusion and exclusion criteria

From: Parenteral and oral antibiotic duration for treatment of pediatric osteomyelitis: a systematic review protocol

Inclusion Exclusion
Randomized Controlled trials Non- randomized trials
Quasi Randomized Trials Cohort, case-series or retrospective studies
All languages Review articles
Acute osteomyelitis Patients >18 years
Children 0 to 18 years Chronic or sub-acute osteomyelitis, tuberculosis, sickle cell disease, malignancy, human immunodeficiency virus, chemotherapy
Published or unpublished Osteomyelitis data cannot be separated from other musculoskeletal/infectious diagnoses
Antibiotic administration with follow-up for 3 months Intervention other than antibiotic
Identify the anti-microbial and its route Route of antimicrobial unclear
Identify duration of therapy Duration of parenteral or enteral therapy unclear
Outcome after 3 months follow-up stated or inferred as clinical cure, failure or relapse Follow-up not documented